USPTO serial 79296446
IBVIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 31, 2022
- Examiner
- MAJCHER HARTNETT, MEGAN K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IBVIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Designing of machines, apparatus, instruments, machine parts, and systems composed of such machines, apparatus and instruments; pharmaceutical, medicine, chemical and engineering design services; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program design, computer programming, and maintenance of computer program for databases; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; information processing using computers, namely, providing online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computers, computers for automobiles and other computers for industrial machines requiring highly specialized knowledge, skills and experiences for proper operation; scientific and technical research consultancy in the field of life information science, nucleic acids diagnosis and drug discovery, and research and development relating thereto; analysis and research in the field of life information science and technology, namely, analysis and research on target identification and validation, and prediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information science, nucleic acids diagnosis and drug discovery; scientific and technological services, namely, biochemical and biological testing, inspection of medical and chemical goods for quality control purposes, efficacy and quality analysis of medical and chemical products, medical and chemical product development and research; chemical analysis and screening on chemicals, namely, chemical product quality evaluation; screening on pharmaceuticals, namely, pharmaceutical product evaluation; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; research services in the field of biological science, namely, isolation, purification, analysis, screening and research on DNA, RNA and other biological materials; quality assessment services, namely, quality control and evaluation for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructures, and providing information and consultancy relating thereto; Scientific and technological services, namely, testing, inspection, analysis, surveying, development and research on small molecule compounds, antisense oligonucleotides and compounds, and providing information and consultancy relating thereto; analysis, surveying and development of pharmaceuticals, and providing information and consultancy relating thereto; testing, inspection and research for drug development and medical research purposes, and providing information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; consultancy, advice and providing information on medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; testing, surveying, research and data analysis for research purposes in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials or bioengineering; testing, inspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testing, inspection and research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing the functionality of and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysis, testing, screening, designing, development or research of nucleic acids, pharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNA, or mRNA, substructures; providing temporary use of online non-downloadable computer programs for creating, accessing, managing and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 20, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 20, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 20, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 11, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 11, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 11, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 15, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 15, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 31, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 31, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 31, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 10, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 21, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 23, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 6, 2022 | ALIE | ASSIGNED TO LIE | — |
| Feb 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 4, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 4, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 4, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2021 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 27, 2021 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 27, 2021 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |